The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA Repair
Open Access
- 1 June 2003
- journal article
- research article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 278 (23), 20582-20592
- https://doi.org/10.1074/jbc.m210992200
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Preferential Platination of an Activated Cellular Promoter by cis-DiamminedichloroplatinumBiochemistry, 1999
- Down-regulation of Tumor Necrosis Factor α Expression by Activating Transcription Factor 2 Increases UVC-induced Apoptosis of Late-stage Melanoma CellsJournal of Biological Chemistry, 1999
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- ATF2 confers radiation resistance to human melanoma cellsOncogene, 1998
- p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficientCurrent Biology, 1996
- Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleusCurrent Biology, 1995
- Rapamycin Selectively Blocks Interleukin-2-induced Proliferating Cell Nuclear Antigen Gene Expression in T LymphocytePublished by Elsevier BV ,1995
- The promoter region of the human type‐I‐DNA‐topoisomerase geneEuropean Journal of Biochemistry, 1993
- Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elementsCell, 1993
- Potentiation of alkylation-induced sister chromatid exchange frequency by 3-aminobenzamide is mediated by intracellular loss of NAD+Carcinogenesis: Integrative Cancer Research, 1986